Recent Finacing
Recent Raise
Generation Bio develops a non-viral, capsid-free gene therapy platform using targeted LNPs, ceDNA, and manufacturing to enable re-dosing and large-gene delivery to liver, muscle, eye, CNS and lung.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Generation Bio.
